Table 3.
Association of differentially expressed genes with experimentally determined PPARγ binding sites.
Group | Total | PPRE+ | PPRE- | PPRE+ % | p-value |
---|---|---|---|---|---|
RZ up # changes >= 1 | 117 | 34 | 83 | 29.06 | 2.50E-06 |
RZ up # changes >= 2 | 65 | 25 | 40 | 38.46 | 1.57E-07 |
RZ up # changes >= 3 | 26 | 15 | 11 | 57.69 | 7.14E-08 |
RZ up # changes >= 4 | 12 | 11 | 1 | 91.67 | 1.49E-09 |
RZ down # changes >= 1 | 706 | 89 | 617 | 12.61 | 5.33E-01 |
RZ down # changes >= 2 | 369 | 52 | 317 | 14.09 | 2.30E-01 |
RZ down # changes >= 3 | 143 | 24 | 119 | 16.78 | 9.29E-02 |
RZ down # changes >= 4 | 12 | 0 | 12 | 0.00 | 1.00E+00 |
RZ up and G-DN down (Table 1) | 7 | 7 | 0 | 100.00 | 5.31E-07 |
RZ down and G-DN up (Table 2) | 10 | 1 | 9 | 10.00 | 7.42E-01 |
Genes expressed in aorta and 3T3-L1 adipocytes | 8661 | 1096 | 7565 | 12.65 | NA |
RZ = rosiglitazone, G-DN = mice with dominant negative PPARγ, up = up-regulated, down = down-regulated.